Cero Therapeutics Holdings, Inc.7月3日成交额为53.02万美元

市场透视2025-07-04

美东时间2025年7月3日，Cero Therapeutics Holdings, Inc.（CERO.US）成交额为53.02万美元，成交额较昨日减少38.27%，当日成交量为5.68万股。Cero Therapeutics Holdings, Inc.（CERO.US）于2025年7月3日跌2.11%，报9.26美元，该股过去5个交易日跌13.3%，年初至今跌92.28%，过去60日跌...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2548061334?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-04 09:29","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2548061334","market":"us","top_or_hot":-1,"title":"Cero Therapeutics Holdings, Inc.7月3日成交额为53.02万美元","media":"市场透视","content":"<div>\n<p>美东时间2025年7月3日，Cero Therapeutics Holdings, Inc.（CERO.US）成交额为53.02万美元，成交额较昨日减少38.27%，当日成交量为5.68万股。Cero Therapeutics Holdings, Inc.（CERO.US）于2025年7月3日跌2.11%，报9.26美元，该股过去5个交易日跌13.3%，年初至今跌92.28%，过去60日跌...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704092940a72daa44&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cero Therapeutics Holdings, Inc.7月3日成交额为53.02万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCero Therapeutics Holdings, Inc.7月3日成交额为53.02万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-04 09:29 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704092940a72daa44&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>美东时间2025年7月3日，Cero Therapeutics Holdings, Inc.（CERO.US）成交额为53.02万美元，成交额较昨日减少38.27%，当日成交量为5.68万股。Cero Therapeutics Holdings, Inc.（CERO.US）于2025年7月3日跌2.11%，报9.26美元，该股过去5个交易日跌13.3%，年初至今跌92.28%，过去60日跌...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704092940a72daa44&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CERO","symbol_name":"CERo Therapeutics Holdings, Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704092940a72daa44&s=b","article_id":"2548061334","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704092940a72daa44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2548061334","pubTimestamp":1751592578,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"美东时间2025年7月3日，Cero Therapeutics Holdings, Inc.成交额为53.02万美元，成交额较昨日减少38.27%，当日成交量为5.68万股。Cero Therapeutics Holdings, Inc.于2025年7月3日跌2.11%，报9.26美元，该股过去5个交易日跌13.3%，年初至今跌92.28%，过去60日跌34.79%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-03|53.02万|-38.27%|5.68万|#|2025-07-02|85.88万|22.72%|9.09万|#|2025-07-01|69.98万|-47.04%|7.50万|#|2025-06-30|132.14万|-46.12%|13.55万|#|2025-06-27|245.26万|-13.78%|24.72万|CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"CERO":"CERo Therapeutics Holdings, Inc.","BK4139":"生物科技","BK4007":"制药","LENZ":"Therapeutics","BK4539":"次新股"},"translate_title":"Cero Therapeutics Holdings, Inc.7 The turnover on March 3 was US $530,200","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CERO":0.9,"LENZ":1},"content_text":"美东时间2025年7月3日，Cero Therapeutics Holdings, Inc.（CERO.US）成交额为53.02万美元，成交额较昨日减少38.27%，当日成交量为5.68万股。Cero Therapeutics Holdings, Inc.（CERO.US）于2025年7月3日跌2.11%，报9.26美元，该股过去5个交易日跌13.3%，年初至今跌92.28%，过去60日跌34.79%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-03|53.02万|-38.27%|5.68万|#|2025-07-02|85.88万|22.72%|9.09万|#|2025-07-01|69.98万|-47.04%|7.50万|#|2025-06-30|132.14万|-46.12%|13.55万|#|2025-06-27|245.26万|-13.78%|24.72万|CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。其专有的T细胞工程方法使其能够将先天免疫和适应性免疫的某些理想特征整合到单一的治疗结构中，旨在利用人体的全部免疫功能，来实现优化的癌症治疗。先导分子是 CER-1236，这是一种靶向新型肿瘤抗原 TIM-4 配体的自体 T 细胞产品。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2548061334","isCrawlerRequest":true}